SCHEMBL1865053

SCHEMBL1865053

NCC(CN)(Cc1ccccc1)NC(=O)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES1 P23141 5/20 0.47
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 2/20 0.43
RECQL P46063 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 1/20 0.43
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
FAAH O00519 3/20 0.41
TSHR P16473 2/20 0.40
CYP2D6 P10635 1/20 0.40
CPA1 P15085 1/20 0.40
MMP8 P22894 5/20 0.38
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412482 0.79 CYP3A4 (0.50) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL6330677 0.77 CYP3A4 (0.64) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL9191753 0.74 CYP3A4 (0.49) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL9191755 0.74 CYP3A4 (0.49) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL24965070 0.74 CYP3A4 (0.49) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL9547513 0.72 SMN1; SMN2 (0.52) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL9551384 0.71 HTT (0.46) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL3787958 0.71 CA12 (0.48) CYP3A4CYP1A2RECQLMAPK1ALDH1A1
SCHEMBL6438136 0.70 SMN1; SMN2 (0.55) CES1CYP3A4CYP1A2RECQLSMN1; SMN2
SCHEMBL7462953 0.70 ALDH1A1 (0.44) CES1CYP3A4CYP1A2RECQLMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496704-A1 THERAPEUTIC COMPOUNDS Rutgers, The State University of New Jersey (US) 2012-09-12 EP disclosed
WO-2011057126-A1 THERAPEUTIC COMPOUNDS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-05-12 WO disclosed